CAJ | 학술논문

目的：探讨支气管动脉造影表现及化疗栓塞术治疗中晚期肺癌的临床效果并对其安全性及技术的可行性进行评价。方法对27例肺癌患者，根据支气管动脉造影情况，分析支气管动脉走行、粗细、有无肋间动脉共干及脊髓动脉显影，是否有肿瘤染色及病变部位、大小、范围，超选择插管，进行栓塞。结果本组27例肺癌经支气管动脉栓塞治疗，按照 WHO 实体瘤疗效判断标准近期有效率为（ CR + PR）19例，占70、4%，稳定（SD）8例占29、6%。其中一例病人于2004年栓塞+介入化疗至今已近8年而依然生存。随访时间最短者9个月最长者90个月。并发症：本组有一例支气管动脉栓塞后出现背部皮肤红斑，一例栓塞后出现右下肢麻木及肌力下降，经治疗后症状好转，无一例严重并发症发生。结论支气管动脉栓塞术治疗肺癌只要选择病人得当，严格按照造影剂低浓度、低流速、超选择插管，避开脊髓动脉等危险支，操作轻柔得当，该方法应能达到提高患者生活质量延长患者带瘤生存时间的目的。
목적：탐토지기관동맥조영표현급화료전새술치료중만기폐암적림상효과병대기안전성급기술적가행성진행평개。방법대27례폐암환자，근거지기관동맥조영정황，분석지기관동맥주행、조세、유무륵간동맥공간급척수동맥현영，시부유종류염색급병변부위、대소、범위，초선택삽관，진행전새。결과본조27례폐암경지기관동맥전새치료，안조 WHO 실체류료효판단표준근기유효솔위（ CR + PR）19례，점70、4%，은정（SD）8례점29、6%。기중일례병인우2004년전새+개입화료지금이근8년이의연생존。수방시간최단자9개월최장자90개월。병발증：본조유일례지기관동맥전새후출현배부피부홍반，일례전새후출현우하지마목급기력하강，경치료후증상호전，무일례엄중병발증발생。결론지기관동맥전새술치료폐암지요선택병인득당，엄격안조조영제저농도、저류속、초선택삽관，피개척수동맥등위험지，조작경유득당，해방법응능체도제고환자생활질량연장환자대류생존시간적목적。
Objective:explore bronchial arteriography performance and chemotherapy embolization in the middle - late stage the clinical effect of lung cancer and to its security and the feasibility of the technology evaluation. Methods:27 cases of patients with lung cancer,according to the bronchial arteriography,analyzes the bronchial arterial line,the thickness, whether go intercostals arteries were dry and spinal cord artery enhancement,whether there is a tumor lesion site,dyeing and size,scope,the choice intubation,embolism. Results:The 27 cases of lung cancer by the bronchial arterial emboliza-tion,according to the WHO solid tumor response judgment standard in the patients for(CR + PR)19 cases,accounting for 70,4% ,stable(SD)8 cases of 29,6%. One patient in 2004 + intervention has been embolization chemotherapy nearly eight years and still survive. Follow - up time the shortest nine months the longest 90 months. Conclusion:Bronchial arteri-al embolization in the lung cancer as long as the choice of the patient is proper,in strict accordance with low concentration and low contrast velocity,super choose intubation,avoid spinal cord artery,and dangerous of teams,operation gently prop-er,this method should be able to improve the quality of life of the patients prolong patient survival with tumor the purpose of the time.